Positive results for new multiple myeloma treatment
11 March, 2013A new treatment for multiple myeloma, developed by Patrys, shows promising results in patients.
Acrux’s underarm testosterone listed on PBS
07 March, 2013 by Dylan Bushell-EmblingAcrux’s (ASX:ACR) underarm testosterone treatment for androgen deficiency has been added to the PBS, via global licensing partner Eli Lilly.
Global biotech crop plantings increase 100-fold
07 March, 2013Last year marked an unprecedented 100-fold increase in biotech crop hectarage.
Collaborative agreement to develop cancer therapies
07 March, 2013 by Susan WilliamsonNovogen has signed a collaborative agreement with the Ingham Institute to begin progressing its pipeline of cancer therapies.
Imugene secures Japanese patent for Linguet
06 March, 2013 by Dylan Bushell-EmblingImugene (ASX:IMU) will receive a Japanese patent that will allow it to explore developing products to treat bone loss using its Linguet drug delivery platform.
Newcastle Uni teams with Proteologics on asthma R&D
06 March, 2013 by Dylan Bushell-EmblingUniversity of Newcastle and Israeli drug developer Proteologics have signed a deal covering joint development of an asthma treatment based on midline-1 inhibitors.
Gene patent ruling appealed
06 March, 2013 by Susan WilliamsonCancer Voices Australia will appeal the Federal Court of Australia’s decision to allow genes to be patented.
Nominations invited for gene technology committees
05 March, 2013The Office of the Gene Technology Regulator is seeking nominations for membership of the Gene Technology Technical Advisory Committee and the Gene Technology Ethics and Community Consultative Committee.
Clinical Network Services appoints leading toxicologist to BioDesk
05 March, 2013Clinical Network Services has appointed toxicologist Dr Doug Francis to its BioDesk consultancy.
Alchemia completes recruitment for colorectal cancer trial
05 March, 2013 by Susan WilliamsonAlchemia (ASX:ACL) has completed enrolment of 415 patients for its Phase III trial of HA-Irinotecan in metastatic colorectal cancer.
Prima Biomed begins recruitment in Europe
05 March, 2013 by Susan WilliamsonPrima BioMed (ASX:PRR) has begun recruiting patients into its ovarian cancer vaccine trial in Europe.
Starpharma seeks patent for dendrimer cancer drug
05 March, 2013 by Dylan Bushell-EmblingSuccessful animal trials of dendrimer-doxorubicin have prompted Starpharma (ASX:SPL) to file for a patent for the formula in preparation for partnership negotiations.
Bionomics to raise $16.4m in rights issue
04 March, 2013 by Dylan Bushell-EmblingBionomics (ASX:BNO) has launched a 1-for-8 rights issue to help raise cash for its drug development programs and improve its ability to independently fund clinical trials.
Major medtech event to feature in Melbourne
28 February, 2013 by AusBiotechThe AusMedtech national medtech conference, now its sixth year, will for the first time be held in Melbourne in May.
Bionomics preps for capital raising
28 February, 2013 by Tim DeanBionomics (ASX:BNO) has entered a trading halt ahead of a capital raising.
